NF-κB
Reviewed by Maurice Lichtenberg
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a family of transcription factors — comprising RelA, RelB, c-Rel, p50 and p52 subunits — that regulate the expression of hundreds of genes involved in inflammation, immunity, cell survival and proliferation. In the canonical pathway, pro-inflammatory signals such as TNF-α, IL-1β, lipopolysaccharide or reactive oxygen species trigger IκB kinase-mediated degradation of inhibitory IκB proteins, releasing NF-κB dimers to translocate to the nucleus and drive target gene expression. NF-κB activity increases with age in multiple tissues and is considered a principal driver of inflammaging, the SASP and age-related immune dysregulation; its activation is also downstream of the cGAS-STING pathway, linking cytosolic DNA sensing to chronic inflammation.
Sources
- Lawrence T. (2009). NF-κB: a key role in inflammatory diseases. *Journal of Clinical Investigation*doi:10.1172/JCI36682
- Pikarsky E, Porat RM, Stein I, et al.. (2004). NF-κB functions as a tumour promoter in inflammation-associated cancer. *Nature*doi:10.1038/nature02924
- Hayden MS, Ghosh S. (2012). NF-κB, the first quarter-century: remarkable progress and outstanding questions. *Genes & Development*doi:10.1101/gad.183434.111
